Trial intelligence / Profile preview

Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms

NCT05028153Phase 2Recruiting

Start
Nov 2022
Primary completion
Nov 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of azithromycin in asthma. Started Nov 2022; status: recruiting.

02

Drugs

azithromycin
03

Conditions

asthma

Beyond the preview

Go deeper on NCT05028153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05028153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call